Literature DB >> 24735036

A novel predictor of cancer malignancy: up-regulation of myristoylated alanine-rich C kinase substrate phosphorylation in lung cancer.

Ching-Hsien Chen1, Chun-Lung Chiu, Kenneth B Adler, Reen Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24735036      PMCID： PMC4098099          DOI： 10.1164/rccm.201401-0053LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

1.  A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis.

Authors:  C-H Chen; P Thai; K Yoneda; K B Adler; P-C Yang; R Wu
Journal:  Oncogene       Date:  2013-08-19       Impact factor: 9.867

2.  PhosphoMARCKS drives motility of mouse melanoma cells.

Authors:  Xiangyu Chen; Susan A Rotenberg
Journal:  Cell Signal       Date:  2010-03-06       Impact factor: 4.315

3.  MARCKS protein is a key molecule regulating mucin secretion by human airway epithelial cells in vitro.

Authors:  Y Li; L D Martin; G Spizz; K B Adler
Journal:  J Biol Chem       Date:  2001-08-31       Impact factor: 5.157

4.  Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.

Authors:  Tsutomu Masaki; Masaaki Tokuda; Shuhei Yoshida; Seiji Nakai; Asahiro Morishita; Naohito Uchida; Toshiharu Funaki; Yuko Kita; Fumi Funakoshi; Takako Nonomura; Takashi Himoto; Akihiro Deguchi; Yasuhiko Kimura; Kunihiko Izuishi; Hisao Wakabayashi; Hisashi Usuki; Hitoshi Yoshiji; Seishiro Watanabe; Kazutaka Kurokohchi; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2005-03       Impact factor: 5.650

5.  Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.

Authors:  Johann Micallef; Michael Taccone; Joydeep Mukherjee; Sidney Croul; Jennifer Busby; Michael F Moran; Abhijit Guha
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

6.  Myristoylated alanine-rich C-kinase substrate (MARCKS) protein regulation of human neutrophil migration.

Authors:  Rachael E Eckert; Laura E Neuder; Joungjoa Park; Kenneth B Adler; Samuel L Jones
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-02       Impact factor: 6.914

7.  A peptide against the N-terminus of myristoylated alanine-rich C kinase substrate inhibits degranulation of human leukocytes in vitro.

Authors:  Shuji Takashi; Joungjoa Park; Shijing Fang; Sekiya Koyama; Indu Parikh; Kenneth B Adler
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-16       Impact factor: 6.914

8.  A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma.

Authors:  Monique Singer; Linda D Martin; B Boris Vargaftig; Joungjoa Park; Achim D Gruber; Yuehua Li; Kenneth B Adler
Journal:  Nat Med       Date:  2004-01-11       Impact factor: 53.440

9.  Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway.

Authors:  Anchalee Techasen; Watcharin Loilome; Nisana Namwat; Eri Takahashi; Eiji Sugihara; Anucha Puapairoj; Masanao Miwa; Hideyuki Saya; Puangrat Yongvanit
Journal:  Cancer Sci       Date:  2009-11-07       Impact factor: 6.716

10.  NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinases.

Authors:  M M Reddy; M S Fernandes; R Salgia; R L Levine; J D Griffin; M Sattler
Journal:  Leukemia       Date:  2010-11-12       Impact factor: 11.528
View more
  11 in total

1.  MARCKS is marked in combating lung cancer growth and acquired resistance.

Authors:  Sekhar P Reddy; Viswanathan Natarajan; Arkadiusz Z Dudek
Journal:  Am J Respir Crit Care Med       Date:  2014-11-15       Impact factor: 21.405

2.  Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.

Authors:  Ching-Hsien Chen; Sarah Statt; Chun-Lung Chiu; Philip Thai; Muhammad Arif; Kenneth B Adler; Reen Wu
Journal:  Am J Respir Crit Care Med       Date:  2014-11-15       Impact factor: 21.405

3.  Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.

Authors:  C-H Chen; L W R Fong; E Yu; R Wu; J F Trott; R H Weiss
Journal:  Oncogene       Date:  2017-02-06       Impact factor: 9.867

4.  ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8 Ubiquitin Ligase.

Authors:  Huibin Yang; Phillip L Palmbos; Lidong Wang; Evelyn H Kim; Gina M Ney; Chao Liu; Jayendra Prasad; David E Misek; Xiaochun Yu; Mats Ljungman; Diane M Simeone
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

Review 5.  MARCKS and Lung Disease.

Authors:  Mary K Sheats; Qi Yin; Shijing Fang; Joungjoa Park; Anne L Crews; Indu Parikh; Brian Dickson; Kenneth B Adler
Journal:  Am J Respir Cell Mol Biol       Date:  2019-01       Impact factor: 6.914

6.  Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosis.

Authors:  Ji-Min Li; David C Yang; Justin Oldham; Angela Linderholm; Jun Zhang; Jun Liu; Nicholas J Kenyon; Ching-Hsien Chen
Journal:  Mol Ther       Date:  2021-01-26       Impact factor: 11.454

7.  Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment.

Authors:  Ching-Hsien Chen; Chun-Ting Cheng; Yuan Yuan; Jing Zhai; Muhammad Arif; Lon Wolf R Fong; Reen Wu; David K Ann
Journal:  Oncotarget       Date:  2015-06-20

8.  MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines.

Authors:  Timothy D Rohrbach; Robert B Jones; Patricia H Hicks; Alice N Weaver; Tiffiny S Cooper; Nicholas J Eustace; Eddy S Yang; John S Jarboe; Joshua C Anderson; Christopher D Willey
Journal:  Oncol Lett       Date:  2016-12-29       Impact factor: 2.967

9.  MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer.

Authors:  Jun Liu; Szu-Jung Chen; Ssu-Wei Hsu; Jun Zhang; Ji-Min Li; David C Yang; Shenwen Gu; Kent E Pinkerton; Ching-Hsien Chen
Journal:  Theranostics       Date:  2021-02-19       Impact factor: 11.556

10.  Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression.

Authors:  David C Yang; Ji-Min Li; Jihao Xu; Justin Oldham; Sem H Phan; Jerold A Last; Reen Wu; Ching-Hsien Chen
Journal:  FASEB J       Date:  2019-10-26       Impact factor: 5.834
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.